Teplizumab, the first drug to delay the onset of type 1 diabetes, is now available on the NHS in England and Wales. Approved by NICE, it gives those at high risk time to delay the condition, offering children and teenagers more years before they must manage the demands of diabetes. This marks a major shift in treatment since insulin was first discovered over a century ago.